Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

2.7K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characteristics of LAZY genes across eight species of Rosaceae and the function of PpLAZY1a on branch angle in peach (Prunus persica).

Gene·2026
Same author

NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Clec3b<sup>+</sup> extraskeletal cells regulate fracture healing and heterotopic ossification.

Bone research·2026
Same author

Jasmonic acid and PpeMYC2 regulate peach fruit ripening by controlling polyamine levels and anthocyanin biosynthesis.

Plant physiology·2026
Same author

Ropeginterferon alfa-2b-njft treatment in essential thrombocythemia across different driver mutations: results from a North American, single-arm, multicentre study (EXCEED-ET).

Lancet regional health. Americas·2026
Same author

Add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: a randomized phase 3 study.

The oncologist·2026

Related Experiment Video

Updated: Jan 9, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

7.9K

Beta-Arrestin 1 Deficiency Enhances Host Anti-Myeloma Immunity Through T Cell Activation and Checkpoint Modulation.

Jian Wu1, Xiaobei Wang1, Shaima Jabbar1

  • 1Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, School of Medicine, Duke University Medical Center, Durham, NC 27710, USA.

International Journal of Molecular Sciences
|December 11, 2025
PubMed
Summary

Beta-arrestin 1 (ARRB1) deficiency boosts anti-myeloma immunity and survival. This study reveals ARRB1 as a key regulator of host immune response against multiple myeloma, suggesting it as a therapeutic target.

Keywords:
PD-1T cell activationbeta-arrestin 1host immunityimmune checkpointmultiple myelomatumor microenvironment

More Related Videos

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity
08:41

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity

Published on: June 7, 2017

8.6K
Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
07:13

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control

Published on: May 24, 2024

905

Related Experiment Videos

Last Updated: Jan 9, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

7.9K
Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity
08:41

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity

Published on: June 7, 2017

8.6K
Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
07:13

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control

Published on: May 24, 2024

905

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Beta-arrestin 1 (ARRB1) is a protein regulating cell signaling.
  • ARRB1's role in host immunity against multiple myeloma (MM) is unknown.
  • ARRB1 is implicated in cancer progression.

Purpose of the Study:

  • To investigate the role of host ARRB1 in anti-myeloma immunity.
  • To determine if ARRB1 deficiency impacts survival in a murine MM model.
  • To explore ARRB1's effect on immune cell populations and function in the context of MM.

Main Methods:

  • Used a syngeneic murine model with Vk*MYC myeloma cells.
  • Compared tumor growth, survival, and immune cell profiles in wild-type versus ARRB1 knockout mice.
  • Assessed T cell infiltration/activation, myeloid populations, and PD-1 expression.

Main Results:

  • Host ARRB1 deficiency significantly enhanced anti-myeloma immunity and prolonged survival.
  • ARRB1 knockout mice showed increased T cell infiltration and activation.
  • Reduced immunosuppressive myeloid populations and decreased PD-1 expression on immune cells were observed.
  • ARRB1 deficiency protected against myeloma-induced bone disease.

Conclusions:

  • Host ARRB1 acts as a negative regulator of anti-myeloma immunity.
  • ARRB1 deficiency enhances host immune response against multiple myeloma.
  • ARRB1 is a potential therapeutic target for improving MM immunotherapy.